Interpretative Phenomenological Analysis (IPA) of Cancer Patients' Lived Experiences with Nanomedicine-Based Drug Delivery Therapy
Main Article Content
Abstract
Nanomedicine-based drug delivery systems represent a significant advancement in cancer treatment, offering targeted therapies that reduce side effects and enhance efficacy. Despite substantial progress in clinical outcomes, little is known about how cancer patients experience and interpret these treatments from a personal and emotional perspective. Specifically, there is a gap in understanding the psychosocial impact and the lived experience of patients undergoing nanomedicine therapies. This study employs Interpretative Phenomenological Analysis (IPA) to explore the subjective experiences of cancer patients receiving nanomedicine treatment, aiming to uncover how they perceive and emotionally respond to this novel therapy. Through in-depth semi-structured interviews with 15 cancer patients, the study identifies key themes including hope versus anxiety, fear, physical discomfort, and a sense of empowerment versus vulnerability. The analysis reveals a complex emotional landscape, where patients balance optimism with anxiety and uncertainty. These findings shed light on the critical importance of psychosocial support and patient-centered care when implementing innovative therapies. This study contributes to a deeper understanding of nanomedicine therapy’s psychosocial effects and underscores the need for future research that integrates both biomedical and emotional aspects to improve patient care.
Article Details
Section
References
Adejoh, S. O., Boele, F., Akeju, D., Dandadzi, A., Nabirye, E., Namisango, E., Namukwaya, E., Ebenso, B., Nkhoma, K., & Allsop, M. J. (2021). The role, impact, and support of informal caregivers in the delivery of palliative care for patients with advanced cancer: A multi-country qualitative study. Palliative Medicine, 35(3), 552–562. Scopus. https://doi.org/10.1177/0269216320974925
Bange, E. M., Doucette, A., Gabriel, P. E., Porterfield, F., Harrigan, J. J., Wang, R., Wojcieszynski, A. P., Boursi, B., Mooney, B. I., Reiss, K. A., & Mamtani, R. (2020). Opportunity costs of receiving palliative chemotherapy for metastatic pancreatic ductal adenocarcinoma. JCO Oncology Practice, 16(8), E678–E687. Scopus. https://doi.org/10.1200/JOP.19.00328
Beeler, W. H., Bellile, E. L., Casper, K. A., Jaworski, E., Burger, N. J., Malloy, K. M., Spector, M. E., Shuman, A. G., Rosko, A., Stucken, C. L., Chinn, S. B., Dragovic, A. F., Chapman, C. H., Owen, D., Jolly, S., Bradford, C. R., Prince, M. E. P., Worden, F. P., Jagsi, R., … Swiecicki, P. L. (2020). Patient-reported financial toxicity and adverse medical consequences in head and neck cancer. Oral Oncology, 101. Scopus. https://doi.org/10.1016/j.oraloncology.2019.104521
Bennardi, M., Diviani, N., Gamondi, C., Stüssi, G., Saletti, P., Cinesi, I., & Rubinelli, S. (2020). Palliative care utilization in oncology and hemato-oncology: A systematic review of cognitive barriers and facilitators from the perspective of healthcare professionals, adult patients, and their families. BMC Palliative Care, 19(1). Scopus. https://doi.org/10.1186/s12904-020-00556-7
Cuccia, F., Mazzola, R., Nicosia, L., Figlia, V., Giaj-Levra, N., Ricchetti, F., Rigo, M., Vitale, C., Mantoan, B., De Simone, A., Sicignano, G., Ruggieri, R., Cavalleri, S., & Alongi, F. (2020). Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy. Radiation Oncology, 15(1). Scopus. https://doi.org/10.1186/s13014-020-01622-3
Dassieu, L., Kaboré, J.-L., Choinière, M., Arruda, N., & Roy, É. (2019). Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis. International Journal of Drug Policy, 71, 150–156. Scopus. https://doi.org/10.1016/j.drugpo.2019.03.023
Downar, J., Fowler, R. A., Halko, R., Huyer, L. D., Hill, A. D., & Gibson, J. L. (2020). Early experience with medical assistance in dying in Ontario, Canada: A cohort study. CMAJ, 192(8), E173–E181. Scopus. https://doi.org/10.1503/cmaj.200016
Ferreri, C. J., Hildebrandt, M. A. T., Hashmi, H., Shune, L. O., McGuirk, J. P., Sborov, D. W., Wagner, C. B., Kocoglu, M. H., Rapoport, A., Atrash, S., Voorhees, P. M., Khouri, J., Dima, D., Afrough, A., Kaur, G., Anderson, L. D., Simmons, G., Davis, J. A., Kalariya, N., … Castaneda Puglianini, O. A. (2023). Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy. Blood Cancer Journal, 13(1). Scopus. https://doi.org/10.1038/s41408-023-00886-8
Hal, W. A., Straza, M. W., Chen, X., Mickevicius, N., Erickson, B., Schultz, C., Awan, M., Ahunbay, E., Allen Li, X., & Paulson, E. S. (2020). Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac. PLoS ONE, 15(8 August). Scopus. https://doi.org/10.1371/journal.pone.0236570
Haque, W., Verma, V., Butler, E. B., & Teh, B. S. (2019). Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States. Journal of Immunotherapy, 42(6), 228–235. Scopus. https://doi.org/10.1097/CJI.0000000000000264
Iyer, G., Tully, C. M., Zabor, E. C., Bochner, B. H., Dalbagni, G., Herr, H. W., Donat, S. M., Russo, P., Ostrovnaya, I., Regazzi, A. M., Milowsky, M. I., Rosenberg, J. E., & Bajorin, D. F. (2020). Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience. Clinical Genitourinary Cancer, 18(5), 387–394. Scopus. https://doi.org/10.1016/j.clgc.2020.02.014
Kaye, E. C., Weaver, M. S., DeWitt, L. H., Byers, E., Stevens, S. E., Lukowski, J., Shih, B., Zalud, K., Applegarth, J., Wong, H.-N., Baker, J. N., & Ullrich, C. K. (2021). The Impact of Specialty Palliative Care in Pediatric Oncology: A Systematic Review. Journal of Pain and Symptom Management, 61(5), 1060-1079.e2. Scopus. https://doi.org/10.1016/j.jpainsymman.2020.12.003
Magnani, C. F., Tettamanti, S., Alberti, G., Pisani, I., Biondi, A., Serafini, M., & Gaipa, G. (2020). Transposon-based CAR T cells in acute leukemias: Where are we going? Cells, 9(6). Scopus. https://doi.org/10.3390/cells9061337
Maguire, R., McCann, L., Kotronoulas, G., Kearney, N., Ream, E., Armes, J., Patiraki, E., Furlong, E., Fox, P., Gaiger, A., McCrone, P., Berg, G., Miaskowkski, C., Cardone, A., Orr, D., Flowerday, A., Katsaragakis, S., Darley, A., Lubowitzki, S., … Donnan, P. T. (2021). Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). The BMJ, 374. Scopus. https://doi.org/10.1136/bmj.n1647
Mason, M. C., Massarweh, N. N., Tzeng, C.-W. D., Chiang, Y.-J., Chun, Y. S., Aloia, T. A., Javle, M., Vauthey, J.-N., & Tran Cao, H. S. (2021). Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience. Annals of Surgical Oncology, 28(11), 6725–6735. Scopus. https://doi.org/10.1245/s10434-020-09536-w